COPD

The 2021 annual report finds that Los Angeles remains the most polluted US city, while negative impacts of climate change and COVID-19 are both linked to increased pollution rates.

A trio of experts from the Cleveland Clinic join Dr. Rizzo for a talk on lung transplant trends and challenges in the US.

The non-invasive device uses air pressure pulsations to help open airways and provide clearance of secretions in patients with disease such as COPD, asthma, and cystic fibrosis.

More than two-thirds of smokers want to quit, but lack proper resources. A prescribing professional could help make up that difference.

The last episode of 2020 caps advances and ongoing research into the most burdensome chronic respiratory disease in the US.

Even study enrollees who never smoked traditional cigarettes face a heightened risk of respiratory disease if they used e-cigarettes.

Investigators conducted an educational intervention aimed at strengthening healthcare providers’ readiness to address issues related to medication adherence.

New data show patients hospitalized with COVID-19 far more frequently suffer from cardiometabolic disease, yet face worse outcomes with COPD.

The trial did not reach full enrollment.

Pulmonary conditions like asthma could often lead to the development of chronic cough.

New data shows nearly 40% of chronic lung disease patients from a Portuguese hospital died within 5 years of initiating respiratory rehabilitation.

Obese-related asthma is considered one of the more severe asthma phenotypes.

Data shows certain personality traits are linked to a COPD patient's likelihood of active or sedentary behaviors.

The added indication makes the GSK single inhaler triple therapy the first of its kind approved for both asthma and COPD in the US.

The chief of thoracic surgery and surgical director of the Northwestern Medicine Lung Transplant Program discusses his unprecedented procedure during the pandemic.

New ERS findings show patients hospitalized for COVID-19 bettered from timelier, personalized rehabilitation plans.

The risk of cardiovascular hospitalizations was associated with increasing PM10 at lag 0.

In a poster presented at ERS, researchers find the complement and coagulation cascades pathway was up-regulated in response to airway presence of Moraxella genera that might suggest an activation of systemic innate immunity in response to Moraxella.

COVID-19 positive patients with COPD demonstrated a greater risk for hospitalization, ICU admission, and need for invasive mechanical ventilation compared with non-COPD patients.

Data suggests treatment with the palliative opioid does not affect PCO2 levels, suggesting it is safe in patients with moderate to severe COPD.

Tiotropium plus olodaterol is more effective for patients with COPD compared with LABA plus inhaled corticosteroids.

A new case study  assesses biopsy and autopsy tissues to characterize pathological patterns in suspected EVALI cases .

New findings suggest differing chronic lung diseases are associated with varying risk factors among COVID-19 patients.

The approval are based on a pair of recent phase 3 trials showing the safety and efficacy of budesonide/glycopyrrolate/formoterol fumarate.

Genomics, in combination with patient demographic risks, could help better inform clinicians of persons at risk for worsened chronic pulmonary burden.